News Home

CytomX Therapeutics Inc (CTMX) Up 3.50% in Premarket Trading

Monday, August 01, 2022 07:16 AM | InvestorsObserver Analysts
CytomX Therapeutics Inc (CTMX) Up 3.50% in Premarket Trading

CytomX Therapeutics Inc (CTMX) is higher by Monday morning, with the stock rising 3.50% in pre-market trading to 1.48. CTMX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 75 out of 146 industries, CytomX Therapeutics Inc ranks higher than 30% of stocks. CytomX Therapeutics Inc has fallen 22.28% over the past month, closing at $1.94 on July 4. During this period of time, the stock fell as low as $1.23 and as high as $2.01. CTMX has an average analyst recommendation of Buy. The company has an average price target of $3.95.

Overall Score - 46
CTMX has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CTMX!
CytomX Therapeutics Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 106 by this metric, CTMX ranks better than 106% of stocks.

Important Dates for Investors in CTMX:

-CytomX Therapeutics Inc is set to release earnings on 8/4/2022. Over the last 12 months, the company has reported EPS of $-1.42. -We do not have a set dividend date for CytomX Therapeutics Inc at this time. Click Here To Get The Full Report on CytomX Therapeutics Inc (CTMX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App